We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+24.56%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$44.3M
AUM Growth
-$127M
Cap. Flow
-$68.9M
Cap. Flow %
-155.44%
Top 10 Hldgs %
83.03%
Holding
39
New
6
Increased
2
Reduced
3
Closed
18

Top Buys

Rank Stock Value
1
GDX icon
VanEck Gold Miners ETF
GDX
+$2.46M
2
SIL icon
Global X Silver Miners ETF NEW
SIL
+$2.41M
3
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$1.75M
4
VRNA
Verona Pharma
VRNA
+$1.27M
5
APLT
Applied Therapeutics
APLT
+$1.08M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$68.4M
2
CRBP icon
Corbus Pharmaceuticals
CRBP
+$833K
3
GLW icon
Corning
GLW
+$773K
4
AEM icon
Agnico Eagle Mines
AEM
+$650K
5
MAG
MAG Silver
MAG
+$599K

Sector Composition

Rank Sector Weight
1 Healthcare 69.17%
2 Financials 3.95%
3 Industrials 3.07%
4 Materials 2.54%
5 Consumer Staples 2.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALDX icon
1
Aldeyra Therapeutics
ALDX
$91.7M
$13.6M 30.6%
1,948,090
+70,785
+4% +$405K
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$6.25M 14.11%
450,422
-450,422
-50% -$68.4M
ALT icon
3
Altimmune
ALT
$539M
$2.86M 6.45%
173,864
– –
GDX icon
4
VanEck Gold Miners ETF
GDX
$23B
$2.63M 5.94%
+91,850
New +$2.46M
SIL icon
5
Global X Silver Miners ETF NEW
SIL
$4.08B
$2.53M 5.7%
+89,700
New +$2.41M
VRNA
6
DELISTED
Verona Pharma
VRNA
$2.49M 5.63%
+95,391
New +$1.27M
GDXJ icon
7
VanEck Junior Gold Miners ETF
GDXJ
$7.06B
$1.89M 4.28%
+53,150
New +$1.75M
APLT
8
DELISTED
Applied Therapeutics
APLT
$1.86M 4.2%
2,450,000
+1,367,877
+126% +$1.08M
BAH icon
9
Booz Allen Hamilton
BAH
$8.7B
$1.36M 3.07%
13,000
– –
CVS icon
10
CVS Health
CVS
$137B
$1.35M 3.05%
14,500
– –
TMO icon
11
Thermo Fisher Scientific
TMO
$211B
$1.16M 2.61%
2,100
– –
AVDL
12
DELISTED
Avadel Pharmaceuticals
AVDL
$1.07M 2.42%
+150,000
New +$1.05M
MO icon
13
Altria Group
MO
$122B
$1.04M 2.34%
22,700
– –
V icon
14
Visa
V
$677B
$1.01M 2.27%
4,850
– –
BX icon
15
Blackstone
BX
$104B
$742K 1.67%
10,000
– –
OR icon
16
OR Royalties Inc
OR
$5.47B
$608K 1.37%
235,000
– –
SA
17
Seabridge Gold
SA
$2.8B
$516K 1.16%
41,000
– –
HOOK
18
DELISTED
HOOKIPA Pharma
HOOK
$40.5K 0.09%
+5,000
New +$54.2K
ENTX icon
19
Entera Bio
ENTX
$101M
$2.58K 0.01%
2,484,275
– –
ABEO icon
20
Abeona Therapeutics
ABEO
$345M
– –
-88,629
Closed -$269K
AEM icon
21
Agnico Eagle Mines
AEM
$72.6B
– –
-15,393
Closed -$650K
ANVS icon
22
Annovis Bio
ANVS
$70.6M
– –
-14,210
Closed -$147K
BTAI icon
23
BioXcel Therapeutics
BTAI
$26.2M
– –
-1,250
Closed -$236K
CNTX icon
24
Context Therapeutics
CNTX
$56.4M
– –
-139,520
Closed -$155K
CRBP icon
25
Corbus Pharmaceuticals
CRBP
$170M
– –
-168,196
Closed -$833K
1
2

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Knoll Capital Management held 39 positions worth $44.3M, down 74% from $171M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Knoll Capital Management withdrew a net $68.9M in Q4 2022, closing 18 positions and reducing 3 holdings. Its most notable exit was Corbus Pharmaceuticals, an estimated $833K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 92% a quarter earlier, followed by Financials and Industrials.

Against the trend, Knoll Capital Management opened a new position in VanEck Gold Miners ETF worth $2.63M.

  • Knoll Capital Management's largest Q4 2022 buy was VanEck Gold Miners ETF: 91,850 shares worth $2.63M.
  • Knoll Capital Management added most to Applied Therapeutics in Q4 2022, an estimated $1.08M increase.
  • Knoll Capital Management's biggest Q4 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $68.4M.
  • Knoll Capital Management fully exited Corbus Pharmaceuticals in Q4 2022, selling an estimated $833K.
  • Knoll Capital Management's ten largest holdings make up 83% of its $44.3M portfolio in Q4 2022.
  • Knoll Capital Management opened 6 new positions and closed 18 in Q4 2022.
  • Knoll Capital Management's portfolio value fell 74% quarter-over-quarter to $44.3M.

Based on Knoll Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.